Month: May 2020

Amsterdam, The Netherlands, May 14, 2020 – Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”) (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company, today announces that three abstracts related to Kiadis’ natural killer (K-NK) cell therapy program have been accepted for presentation at the virtual edition of the 25th European Hematology Association (EHA) Congress taking place June 11 – 14, 2020.The EHA abstracts are now available at www.ehaweb.org. Details of the presentations are as follows:·  Abstract #S284: This oral presentation will show clinical data that FC21-NK cells persist in vivo.Abstract DetailsTitle: Early-phase Clinical Trials of Adoptive Transfer of Hyperfunctional NK Cells Expanded Ex Vivo with IL-21 Demonstrate Functional, Phenotypic, and Haplotype-specific evidence of in vivo persistencePresenter:...

Amsterdam, 14 mei 2020 – Kiadis Pharma NV (“Kiadis Pharma” of de “Onderneming”) (Euronext Amsterdam en Brussel: KDS), een biofarmaceutisch bedrijf gericht op onderzoek in de klinische fase, kondigt aan dat drie presentaties over het Kiadis K-NK celtherapieprogramma, zijn geaccepteerd voor presentatie tijdens de (virtuele) editie van het 25e European Hematology Association (EHA) Congres dat plaatsvindt van 11 – 14 juni 2020.De EHA-presentaties zijn nu beschikbaar op www.ehaweb.org. Details van de presentaties zijn als volgt:·  Presentatie #S284: Deze presentatie laat op basis van klinische studieresultaten zien dat FC21-NK cellen langdurig aanwezig zijn in de patient.Details van de presentatieTitel: Early-phase Clinical Trials of Adoptive Transfer of Hyperfunctional NK Cells Expanded Ex Vivo with IL-21...

TORONTO, May 14, 2020 (GLOBE NEWSWIRE) — Loncor Resources Inc. (“Loncor” or the “Company“) (TSX: “LN”; OTCQB: “LONCF”) is pleased to provide an update on its activities within the Ngayu Greenstone Belt, where the Company has a dominant foot-print through its joint venture with Barrick Gold (Congo) SARL (“Barrick”) and on its own majority-owned exploration licences and exploitation concessions, including the Imbo exploitation concession (76.29%) that contains the Adumbi deposit and its wholly-owned exploration licence containing the Makapela depositBarrick Joint VentureLoncor recently received the quarterly exploration report from joint venture partner Barrick for the first quarter of 2020. As announced in February 2020, joint venture partner and operator Barrick had identified a number...

NASHVILLE, Tenn., May 14, 2020 (GLOBE NEWSWIRE) — SmileDirectClub, Inc. (Nasdaq: SDC) today announced the appointment of seven experts in dentistry and orthodontia to its Clinical Advisory Board. Senator Bill Frist, who has a medical background with over 35 years in virtual care and sits on the board of TelaDoc (NYSE:TDOC), will also join SmileDirectClub’s clinical board as Honorary Chair. The specialized board provides strategic counsel to SmileDirectClub and its affiliated network of doctors, as well as advice as to SmileDirectClub’s continued mission of quality and clinical outcomes. The vast and diverse dental experience of the board will be an important resource for SmileDirectClub to continue enhancing brighter, straighter smiles through its leading clear aligner therapy platform and line of premium oral care products.Members...

As previously announced on 18 April 2019, 23 December 2020 and 10 January 2020, Mr. Jens Gisle Schnelle, CFO of Team Tankers International Ltd. (the “Company”), has on certain conditions been granted equity awards in the Company as a part of his incentive program. Mr. Schnelle has today received 330,000 shares (the “Vested Shares”) and 200,000 options have vested (the “Vested Options”). The Vested Options have an exercise price of NOK 6.00 and expires 14 May 2021.Mr. Schnelle has not paid any cash consideration for the Vested Shares or the Vested Options. Following the distribution of the Vested Shares and Vested Options, Mr. Schnelle holds (1) 331,075 shares in the Company and (2) options to acquire 200,000 shares in the Company. The Company has issued to date a total of 209,578,173 shares of which...

MONTRÉAL, May 14, 2020 (GLOBE NEWSWIRE) — Saputo Inc. (TSX:SAP) – A conference call for analysts and institutional investors will be held on Thursday, June 4, 2020, at 2:30 p.m. (Eastern Time), to discuss the fiscal 2020 results.The conference call will begin with a short presentation followed by a question and answer period. The speakers will be Mr. Lino Saputo, Jr., Chair of the Board and Chief Executive Officer, Mr. Maxime Therrien, Chief Financial Officer and Secretary, and Mr. Kai Bockmann, President and Chief Operating Officer, Saputo Inc. and International Sector.To participate in the conference: 1-800-926-9908Please dial-in approximately 10 minutes before the call.To listen to the call on the Web: http://www.gowebcasting.com/10644.Replay of the conferenceA replay of the conference call will be available until Thursday, June...

MONTRÉAL, 14 mai 2020 (GLOBE NEWSWIRE) — Saputo inc. (TSX : SAP) – Une conférence téléphonique pour les analystes et les investisseurs institutionnels, traitant des résultats de l’exercice 2020, aura lieu le jeudi 4 juin 2020, à 14 h 30 (heure de l’Est).La conférence débutera par une courte présentation, suivie d’une période de questions. Les conférenciers seront M. Lino Saputo, Jr., président du conseil d’administration et chef de la direction, M. Maxime Therrien, chef de la direction financière et secrétaire ainsi que M. Kai Bockmann, président et chef de l’exploitation, Saputo inc. et Secteur International.Pour participer à la conférence : 1-800-926-9908Veuillez SVP signaler ce numéro 10 minutes avant le début de la conférence.Pour écouter cet appel sur le Web : http://www.gowebcasting.com/10643.Enregistrement différé de...

MONTRÉAL, May 14, 2020 (GLOBE NEWSWIRE) — Saputo Inc. (TSX:SAP) – A conference call for analysts and institutional investors will be held on Thursday, June 4, 2020, at 2:30 p.m. (Eastern Time), to discuss the fiscal 2020 results.The conference call will begin with a short presentation followed by a question and answer period. The speakers will be Mr. Lino Saputo, Jr., Chair of the Board and Chief Executive Officer, Mr. Maxime Therrien, Chief Financial Officer and Secretary, and Mr. Kai Bockmann, President and Chief Operating Officer, Saputo Inc. and International Sector.To participate in the conference: 1-800-926-9908Please dial-in approximately 10 minutes before the call.To listen to the call on the Web: http://www.gowebcasting.com/10644.Replay of the conferenceA replay of the conference call will be available until Thursday, June...

– MCLA-128, zenocutuzumab, independent epidemiology analysis reaffirms significant clinical and commercial potential in NRG1 fusion cancers –– MCLA-117 demonstrates limited clinical activity in Phase 1 trial –– Extensive panel of novel CD3 bispecific antibodies provides important insights and avenues to maximize T‑cell engager biology –UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 14, 2020 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS) (“Merus”, the “Company”, “we”, or “our”), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics™), today announced the acceptance of six abstracts at upcoming cancer medical meetings. Four abstracts regarding zenocutuzumab (“Zeno”), including results from an independent epidemiology study of the prevalence of NRG1 gene fusion-positive...

DAVIS, Calif., May 14, 2020 (GLOBE NEWSWIRE) — Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, announced today that REGALIA® MAXX biofungicide received the first approval for indoor and outdoor use on cannabis and hemp in Canada.Cannabis and hemp have been relatively small crops in Canada until lifestyle cannabis was approved in 2018. According to Health Canada, 77,800 acres of hemp were grown in 2018, valued at an estimated $50 million USD. And while 2019 acres are still being compiled, Canada Health has reported a 51% increase in licenses issued to grow hemp across Canada in 2019.The majority of Canadian cannabis and hemp acres have been certified organic, as growers have been forced to meet strict standards of a highly regulated industry. There...